Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Albemarle Corp. (ALB) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Albemarle Corp.Trade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Albemarle Corp. vs Marsh & McLennan Companies, Inc. — how do they compare? Albemarle Corp. trades at $127.63 (market cap $15.27B), while Marsh & McLennan Companies, Inc. trades at $188.67 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 6× Albemarle Corp.'s market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.07%). Which is the better fit depends on your goals.

ALBMRSH
Market Cap
$15.27B$91.27B
Sector
Basic MaterialsFinancials
52-Week High
$215.62$211.21
52-Week Low
$72.58$157.32
Enterprise Value
$17.75B$111.95B
Dividend Yield
1.27%2.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Albemarle Corp.

ALB trades at $128.21, down 2.29% today, amid a mixed technical picture with bullish moving averages but overbought RSI signals. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.75, driven by improved lithium pricing and cost savings. Revenue for 2025 was $5.14B, though net income remained negative at -$510.63M. Analyst consensus is a Buy with a $184.50 price target, reflecting optimism for recovery.

Outlook is cautiously optimistic as lithium demand supports earnings growth, but Q3 guidance warns of sequential declines. Key risks include volatile lithium prices and execution challenges. The stock offers potential upside to analyst targets if operational improvements continue, but investors face margin pressure and macroeconomic headwinds.

Marsh & McLennan Companies, Inc.

Marsh & McLennan (MRSH) trades at $189.13, down 0.87% on the day, with a bullish technical signal and strong fundamental performance. Recent earnings beats in Q2 2026, with EPS of $2.96 versus $2.88 expected, and 6% revenue growth highlight operational strength. The company announced the acquisition of Accel to expand its Midwest insurance reach, signaling strategic growth. Valuation metrics show a P/E of 23.35 and robust profitability with a net income margin of 14.24%.

The outlook remains positive with a consensus price target of $202.89, offering potential upside. Risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity is mixed, with Bank of America reducing its stake while others like Bank of Nova Scotia increased holdings. The stock presents a solid long-term growth opportunity amid cyclical insurance sector headwinds.

Returns comparison

Trailing returns across standard periods

About Albemarle Corp.

Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.

Read more on ALB

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH